APA (7th ed.) Citation

E, T., M, S., A, A., C, T., G, N., A, B., . . . I, T. (2024). Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia. Blood cell therapy, 7(3), 75. https://doi.org/10.31547/bct-2024-005

Chicago Style (17th ed.) Citation

E, Tamellini, et al. "Long-term Remissions with Gilteritinib in Early Relapse After Allogeneic Stem Cell Transplantation of FLT3/NPM1 Mutated Acute Myeloid Leukemia." Blood Cell Therapy 7, no. 3 (2024): 75. https://doi.org/10.31547/bct-2024-005.

MLA (9th ed.) Citation

E, Tamellini, et al. "Long-term Remissions with Gilteritinib in Early Relapse After Allogeneic Stem Cell Transplantation of FLT3/NPM1 Mutated Acute Myeloid Leukemia." Blood Cell Therapy, vol. 7, no. 3, 2024, p. 75, https://doi.org/10.31547/bct-2024-005.